Name: Nasus Pharma Ltd. (NSRX) Balance Sheet
Creator: FinSpry

Nasus Pharma Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Nasus Pharma Ltd. (NSRX) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022
Period Ending	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	0.28	0.19	0.15
Cash & Short-Term Investments	0.28	0.19	0.15
Accounts Receivable	0.12	0.00	0.00
Inventory	0.00	0.00	0.00
Other Current Assets	0.15	0.23	0.25
Total Current Assets	0.46	0.44	0.42
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00
Total Non-Current Assets	0.26	0.00	0.00
Total Assets	0.72	0.44	0.42
Current Liabilities
Accounts Payable	0.65	0.66	0.77
Short-Term Debt	1.80	2.46	1.57
Accrued Liabilities	0.99	0.62	0.35
Other Current Liabilities	0.49	0.51	0.51
Total Current Liabilities	3.93	4.24	3.20
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	0.00
Total Liabilities	3.93	4.24	3.20
Stockholders' Equity
Common Stock	0.02	0.02	0.00
Retained Earnings	-12.66	-11.13	-10.08
Additional Paid-in Capital	9.43	7.32	7.29
Shares Outstanding	9.06	9.06	9.06
Total Stockholders' Equity	-3.21	-3.80	-2.79
Total Liabilities & Equity	0.72	0.44	0.42